Company News
Context Therapeutics Gains 2.7% After Russell Inclusion
Context Therapeutics shares rose 2.7% in after‑hours trading following its addition to the Russell 2000 and Russell 3000 indexes.
The inclusion became effective at the close of U.S. equity markets on
